Drug Side Effect Symptoms and Adherence to Antihypertensive Medication

American Journal of Hypertension

Volumn 29, Issue 6, 2016, Pages 772-779

  Tedla, Yacob G ^a   Bautista, Leonelo E ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

blood pressure; cohort study; drug side effects; hypertension; medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ADVERSE DRUG REACTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLURRED VISION; COUGHING; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HEARTBURN; HUMAN; HYPERTENSION; INSOMNIA; LEG SWELLING; LETHARGY; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MICTURITION DISORDER; MOOD CHANGE; MUSCLE CRAMP; PATIENT COMPLIANCE; PENIS ERECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; VISUAL DISORDER; VOMITING; WEAKNESS; XEROSTOMIA; AGED; LONGITUDINAL STUDY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; YOUNG ADULT;

EID: 84973483693     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpv185     Document Type: Article

References (40)

1. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37:869-874
2. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009; 25:2303-2310
3. Bautista LE, Vera-Cala LM, Colombo C, Smith P. Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens 2012; 25:505-511
4. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336:1114-1117
5. Morgan SG, Yan L. Persistence with hypertension treatment among community-dwelling BC seniors. Can J Clin Pharmacol 2004; 11:e267-e273
6. Morgado M, Rolo S, Macedo AF, Pereira L, Castelo-Branco M. Predictors of uncontrolled hypertension and antihypertensive medication nonadherence. J Cardiovasc Dis Res 2010; 1:196-202
7. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605
8. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43:521-530
9. Iyer AS, Ahmed MI, Filippatos GS, Ekundayo OJ, Aban IB, Love TE, Nanda NC, Bakris GL, Fonarow GC, Aronow WS, Ahmed A. Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensitymatched prospective population study. J Am Soc Hypertens 2010; 4:22-31
10. Klungel OH, Kaplan RC, Heckbert SR, Smith NL, Lemaitre RN, Longstreth WT Jr, Leufkens HG, de Boer A, Psaty BM. Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 2000; 31:420-424
11. Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol 2008; 18:302-309
12. Toyoshima H, Takahashi K, Akera T. The impact of side effects on hypertension management: a Japanese survey. Clin Ther 1997; 19:1458-1469
13. Bardage C, Isacson DG. Self-reported side-effects of antihypertensive drugs: an epidemiological study on prevalence and impact on healthstate utility. Blood Press 2000; 9:328-334
14. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356:1255-1259
15. Gregoire JP, Moisan J, Guibert R, Ciampi A, Milot A, Gaudet M, Cote I. Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol 2002; 55:728-735
16. Lin Y, Huang Y, Yang Y, Wu J, Chang C, Lu F. Adherence to antihypertensive medications among the elderly: a community-based survey in Tainan City, Southern Taiwan. Taiwan Geriatr Gerontol 2007; 2:176-189
17. Thoresen M. A note on correlated errors in exposure and outcome in logistic regression. Am J Epidemiol 2007; 166:465-471
18. Kristensen P. Bias from dependent errors in observational studies. Tidsskr Nor Laegeforen 2005; 125:173-175
19. Anderson RB, Hollenberg NK, Williams GH. Physical symptoms distress index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Arch Intern Med 1999; 159: 693-700
20. Erickson SR, Williams BC, Gruppen LD. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy 2004; 24:344-350
21. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980; 2:757-764
22. Greenland S PJ, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999; 10:37-48
23. Pearl J. Causal diagrams and the identification of causal effects. In Pearl J (ed), Causality: Models, Reasoning, and Inference. Cambridge University Press: New York, 2000
24. Textor J, Hardt J, Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 2011; 22:745
25. Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol 2008; 8:70
26. Elwert F. Graphical causal models. In Morgan SL (ed), Handbook of Causal Analysis for Social Research. Springer: New York, 2013
27. Twisk J. Applied Longitudinal Data Analysis for Epidemiology. A Practical Guide. Cambridge University Press: Cambridge, UK, 2003
28. StataCorp. Stata Statistical Software: Release StataCorp LP: College Station, TX, 2013
29. Twisk JR. Sample size calculation. In Twisk JR (ed), Applied Longitudinal Data Analysis for Epidemiology. Cambridge University Press: Cambridge, UK, 2003
30. Haukoos JS, Lewis RJ. Advanced statistics: bootstrapping confidence intervals for statistics with "difficult" distributions. Acad Emerg Med 2005; 12:360-365
31. Sambath KA, Ramanujam R, Chinnaiyan P. Survival analysis: Kaplan-Meier and life table estimates for time to event clinical trial tuberculosis data. Concept Pure Appl Sci 2013; 1:17-21
32. Bloom BS. Daily regimen and compliance with treatment: fewer daily doses and drugs with fewer side effects improve compliance. BMJ 2001; 323:647
33. Bautista LE. Response to "depression and adherence to antihypertensive therapy". Am J Hypertens 2008; 21:726
34. Morgan M, Watkins CJ. Managing hypertension: beliefs and responses to medication among cultural groups. Sociol Health Illn 1988; 10:561-78
35. Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation 2011; 123:1611-1621
36. Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG. Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr 2006; 136:479-483
37. Brain C, Sameby B, Allerby K, Lindstrom E, Eberhard J, Burns T, Waern M. Twelve months of electronic monitoring (MEMS) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia. Eur Neuropsychopharmacol 2014; 24:215-222
38. Nohr EA, Frydenberg M, Henriksen TB, Olsen J. Does low participation in cohort studies induce bias? Epidemiology 2006; 17:413-418
39. Guerrero D, Rudd P, Bryant-Kosling C, Middleton B, Middleton B. Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens 1993; 6:586-592
40. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs 2003; 2:219-228